Trial intelligence / Profile preview

EISO Cream for Molluscum Contagiosum in Pediatric Subjects

NCT02024581Phase 2Terminated

Sponsor
ViroXis
Start
Feb 2016
Primary completion
Sep 2017
Modality
Transdermal Patches, Hydrogel Systems, Classical Binding Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in molluscum contagiosum (MC) comparing 10% East Indian sandalwood oil cream with Placebo cream (2 arms). Primary endpoint: Safety profile of the treatment at 90 Days. Started Feb 2016; status: terminated.

02

Drugs

east indian sandalwood oil cream
03

Conditions

molluscum contagiosum (MC)

Beyond the preview

Go deeper on NCT02024581.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02024581.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call